English  |  正體中文  |  简体中文  |  總筆數 :2853469  
造訪人次 :  45167100    線上人數 :  857
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"鮑柏穎 bo ying bao"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 71-79 / 79 (共8頁)
<< < 1 2 3 4 5 6 7 8 
每頁顯示[10|25|50]項目

機構 日期 題名 作者
中國醫藥大學 2007-03 Docetaxel-induced growth inhibition and apoptosis in androgen independent prostate cancer cells are enhanced by 1alpha,25-dihydroxyvitamin D3 (Ting HJ); (Hsu J); 鮑柏穎(Bo-Ying Bao); (Lee YF)*
中國醫藥大學 2007-03 Evaluation of C-2-substituted 19-nor-1alpha,25-dihydroxyvitamin D3 analogs as therapeutic agents for prostate cancer (Chen TC)*; (Persons KS); (Zheng S); (Mathieu J); (Holick MF); (Lee YF); 鮑柏穎(Bo-Ying Bao); (Arai MA); (Kittaka A)
中國醫藥大學 2006-09 1alpha, 25-dihydroxyvitamin D3 suppresses interleukin-8-mediated prostate cancer cell angiogenesis 鮑柏穎(Bo-Ying Bao); (Yao J); (Lee YF)*
中國醫藥大學 2006-06-24 Activation of 1alpha,25-dihydroxyvitamin D3 receptor by DNA damage signal reduces DNA damages and enhances expression of DNA repair genes 鮑柏穎(Bo-Ying Bao); (HJ Ting); (YF Lee)*
中國醫藥大學 2006-01-? 1alpha,25-dihydroxyvitamin D3 inhibits prostate cancer cell invasion via modulation of selective proteases? 鮑柏穎(Bo-Ying Bao); (Yeh SD); (Lee YF)*?
中國醫藥大學 2005-02-? Androgen-receptor coregulators mediate the suppressive effect of androgen signals on vitamin D receptor activity? 鮑柏穎(Bo-Ying Bao); (Ting HJ); (Hsu CL); (Lee YF)?
中國醫藥大學 2004-10? Modulation of the retinoic acid-induced cell apoptosis and differentiation by the human TR4 orphan nuclear receptor? (Lee YF); 鮑柏穎(Bo-Ying Bao); (Chang C)?
中國醫藥大學 2004-04 Androgen signaling is required for the vitamin D-mediated growth inhibition in human prostate cancer cells 鮑柏穎(Bo-Ying Bao); (Hu YC); (Ting HJ); (Lee YF)*
中國醫藥大學 2004-01 Androgen suppresses PML protein expression in prostate cancer CWR22R cells (Yang L); (Yeh SD); (Xie S); (Altuwaijri S); (Ni J); (Hu YC); (Chen YT); 鮑柏穎(Bo-Ying Bao); (Su CH); (Chang C)*

顯示項目 71-79 / 79 (共8頁)
<< < 1 2 3 4 5 6 7 8 
每頁顯示[10|25|50]項目